Your browser doesn't support javascript.
loading
ARG1 and CXCL2 are potential biomarkers target for psoriasis patients.
Wang, Huilin; Chen, Wenjun; Lie, Caihua; Zhang, Yijie; Li, Jiajia; Meng, Jilong; Zhang, Nan.
  • Wang H; Department of Dermatology, General Hospital of Xinjiang Military Command, Urumqi, China.
  • Chen W; Department of Dermatology, General Hospital of Xinjiang Military Command, Urumqi, China.
  • Lie C; Department of Nephrology, General Hospital of Xinjiang Military Command, Urumqi, China.
  • Zhang Y; Department of Stomatology, General Hospital of Xinjiang Military Command, Urumqi, China.
  • Li J; Xinjiang Key Laboratory of Special Environmental Medicine, General Hospital of Xinjiang Military Command, Urumqi, China.
  • Meng J; Department of Dermatology, General Hospital of Xinjiang Military Command, Urumqi, China.
  • Zhang N; Department of Dermatology, General Hospital of Xinjiang Military Command, Urumqi, China.
Mol Pain ; 18: 17448069221128423, 2022 04.
Article en En | MEDLINE | ID: mdl-36073801
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Interleucina-17 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Interleucina-17 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article